Cole Gibwa, Miller Duncan, Ebrahim Tasneem, Dreyden Tannith, Simpson Rory, Manie Shamila
Department of Physiotherapy, University of Cape Town, South Africa.
S Afr J Physiother. 2016 Jun 30;72(1):307. doi: 10.4102/sajp.v72i1.307. eCollection 2016.
In South Africa, pulmonary tuberculosis (PTB) remains a problem of epidemic proportions. Despite evidence demonstrating persistent lung impairment after PTB cure, few population-based South African studies have investigated this finding. Pulmonary rehabilitation post-cure is not routinely received.
To determine the effects of PTB on lung function in adults with current or past PTB. To determine any association between PTB and chronic obstructive pulmonary disease (COPD).
This study was observational and cross-sectional in design. Participants ( = 55) were included if they were HIV positive on treatment, had current PTB and were on treatment, and/or had previous PTB and completed treatment or if they were healthy adult subjects with no history of PTB. A sample of convenience was used with participants coming from a similar socio-economic background and undergoing spirometry testing. Multiple regression analyses were conducted on each lung function variable.
Compared to normal percentage-predicted values, forced expiratory volume in 1 second (FEV), forced vital capacity (FVC) and FEV:FVC were significantly reduced in those with current PTB by 23.39%, 15.99% and 6.4%, respectively. Both FEV and FVC were significantly reduced in those with past PTB by 11.76% and 10.79%, respectively. There was no association between PTB and COPD - those with previous PTB having a reduced FEV:FVC (4.88% less than the norm), which was just short of significance ( = 0.059).
Lung function is reduced both during and after treatment for PTB and these deficits may persist. This has implications regarding the need for pulmonary rehabilitation even after medical cure.
在南非,肺结核(PTB)仍然是一个具有流行规模的问题。尽管有证据表明肺结核治愈后肺部仍持续受损,但南非很少有基于人群的研究调查这一发现。治愈后进行肺康复治疗并非常规操作。
确定肺结核对现患或既往患肺结核的成年人肺功能的影响。确定肺结核与慢性阻塞性肺疾病(COPD)之间的任何关联。
本研究采用观察性横断面设计。纳入标准为正在接受治疗的HIV阳性患者、现患肺结核且正在接受治疗的患者,和/或既往患肺结核且已完成治疗的患者,或者是无肺结核病史的健康成年受试者。采用便利抽样,参与者来自相似的社会经济背景并接受肺活量测定。对每个肺功能变量进行多元回归分析。
与正常预测值百分比相比,现患肺结核患者的1秒用力呼气量(FEV)、用力肺活量(FVC)和FEV:FVC分别显著降低了23.39%、15.99%和6.4%。既往患肺结核患者的FEV和FVC分别显著降低了11.76%和10.79%。肺结核与COPD之间无关联——既往患肺结核患者的FEV:FVC降低(比正常低4.88%),但未达到显著水平(P = 0.059)。
肺结核治疗期间和治疗后肺功能均会降低,且这些缺陷可能会持续存在。这意味着即使在药物治愈后仍需要进行肺康复治疗。